Human neuroblastoma cells exposed to hypoxia:: induction of genes associated with growth, survival, and aggressive behavior

被引:103
作者
Jögi, A
Vallon-Christersson, J
Holmquist, L
Axelson, H
Borg, Å
Påhlman, S
机构
[1] Lund Univ, Univ Hosp MAS, Dept Lab Med, Div Mol Med, S-20502 Malmo, Sweden
[2] Lund Univ, Dept Oncol, S-22100 Lund, Sweden
关键词
dedifferentiation; differentiation; hypoxia; microarray; neuroblastoma; survival; tumor;
D O I
10.1016/j.yexcr.2004.01.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have recently found that cells derived from human neuroblastoma, a sympathetic nervous system (SNS) tumor, dedifferentiate and acquire a neural crest-like phenotype when exposed to hypoxia. In the present study, global analysis of gene expression and quantitative PCR of relevant genes showed that hypoxia provokes a general adaptive response in neuroblastoma cells and confirm loss of the neuronal phenotype and gain of stem-cell characteristics. Of the approximately 17,000 genes and ESTs analyzed, 199 were consistently upregulated and 36 were downregulated more than 2-fold by hypoxia. As anticipated, several genes involved in glucose and iron metabolism and neovascularization were upregulated, the latter group we here show to include the gene encoding chromogranin C and its cleavage product, secretoneurin, a vascular smooth muscle cell mitogen. We also observed upregulation of genes implicated in cell survival and growth, such as vascular endothelial growth factor (VEGF), neuropilin 1, adrenomedullin, and IGF-2. Several metallothioneins, which are linked to tumor drug resistance, were upregulated, whereas the expression of MDR1 decreased. In hypoxic neuroblastoma cells, proneuronal lineage specifying transcription factors, and their dimerization partner E2-2, were downregulated, whereas their inhibitors Id2 and HES-1 were induced, providing a molecular mechanism for the hypoxia-provoked dedifferentiation of neuroblastoma cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:469 / 487
页数:19
相关论文
共 90 条
[1]  
Bachelder RE, 2001, CANCER RES, V61, P5736
[2]  
Bachelder RE, 2003, CANCER RES, V63, P5230
[3]  
Bae SK, 1999, CANCER RES, V59, P5989
[4]   Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis [J].
Baek, JH ;
Jang, JE ;
Kang, CM ;
Chung, HY ;
Kim, ND ;
Kim, KW .
ONCOGENE, 2000, 19 (40) :4621-4631
[5]   THE PROTEIN ID - A NEGATIVE REGULATOR OF HELIX-LOOP-HELIX DNA-BINDING PROTEINS [J].
BENEZRA, R ;
DAVIS, RL ;
LOCKSHON, D ;
TURNER, DL ;
WEINTRAUB, H .
CELL, 1990, 61 (01) :49-59
[6]  
BERTHOLD F, 2003, FASEB J, V17, P598
[7]  
BJELFMAN C, 1990, CANCER RES, V50, P6908
[8]  
Brizel DM, 1996, CANCER RES, V56, P941
[9]   REVISIONS OF THE INTERNATIONAL CRITERIA FOR NEUROBLASTOMA DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT [J].
BRODEUR, GM ;
PRITCHARD, J ;
BERTHOLD, F ;
CARLSEN, NLT ;
CASTEL, V ;
CASTLEBERRY, RP ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
HEDBORG, F ;
KANEKO, M ;
KEMSHEAD, J ;
LAMPERT, F ;
LEE, REJ ;
LOOK, AT ;
PEARSON, ADJ ;
PHILIP, T ;
ROALD, B ;
SAWADA, T ;
SEEGER, RC ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) :1466-1477
[10]   Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies [J].
Brown, JM .
MOLECULAR MEDICINE TODAY, 2000, 6 (04) :157-162